Cargando…
Estimation of Risk of Recurrence and Toxicity Among Oncologists and Patients With Resected Breast Cancer: A Quantitative Study
Shared decision-making regarding adjuvant systemic therapy in breast cancer is based on both properly conveying information about the prognosis of the disease and the benefits and risks of adjuvant treatment, as well as the patient’s ability to understand this information. This work proposed to anal...
Autores principales: | Ciria-Suarez, Laura, Jimenez-Fonseca, Paula, Hernández, Raquel, Rogado, Jacobo, Calderon, Caterina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653019/ https://www.ncbi.nlm.nih.gov/pubmed/33192784 http://dx.doi.org/10.3389/fpsyg.2020.540083 |
Ejemplares similares
-
Perceived Dignity of Advanced Cancer Patients and Its Relationship to Sociodemographic, Clinical, and Psychological Factors
por: Obispo, Berta, et al.
Publicado: (2022) -
Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic Study
por: Carmona-Bayonas, Alberto, et al.
Publicado: (2023) -
Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy
por: Carmona-Bayonas, Alberto, et al.
Publicado: (2021) -
The Role of Financial Difficulties as a Mediator between Physical Symptoms and Depression in Advanced Cancer Patients
por: Lee, Eun Mi, et al.
Publicado: (2023) -
Clinicians’ and Advanced Cancer Patients’ Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment
por: Lee, Eun Mi, et al.
Publicado: (2023)